Advertisement
Canada markets open in 6 hours 16 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7328
    +0.0005 (+0.07%)
     

  • CRUDE OIL

    84.11
    +0.54 (+0.65%)
     

  • Bitcoin CAD

    87,717.83
    -42.52 (-0.05%)
     

  • CMC Crypto 200

    1,390.21
    -6.33 (-0.45%)
     

  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,759.25
    +191.75 (+1.09%)
     

  • VOLATILITY

    15.37
    0.00 (0.00%)
     

  • FTSE

    8,078.86
    0.00 (0.00%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Company News For Jan 8, 2020

Zacks Equity Research

  • Shares of Cellect Biotechnology Ltd. APOP surged 70.4% after the company received "Intention to Grant" patents from European and Israeli patent offices.

  • Shares of Apache Corporation APA gained 26.8% after the company, with Total SA, said it had discovered considerable oil volumes at the Maka Central-1 well drilled offshore Suriname.

  • Shares of Microchip Technology Incorporated MCHP gained 6.7% after the company raised its Q3 fiscal 2020 consolidated net sales guidance from $1.244-$1.298 billion to $1.281 billion-$1.288 billion.

  • Shares of CTI Industries Corporation CTIB declined 30% after the company executed a non-binding letter of intent to divest its subsidiary in Guadalajara, Mexico for about $4 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apache Corporation (APA) : Free Stock Analysis Report
 
CTI Industries Corporation (CTIB) : Free Stock Analysis Report
 
Microchip Technology Incorporated (MCHP) : Free Stock Analysis Report
 
Cellect Biotechnology Ltd. (APOP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.